Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 01, 2011
This advanced form of a highly purified novel vaccine, developed by a leading vaccine company in Japan promises to provide highly effective protection from a severely debilitating infection while exhibiting a superior patient safety profile.
read more
Tuesday, November 08, 2011
Sentinel Capital Partners, a private equity firm that invests in promising lower middle market companies, today announced its acquisition of WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription ...
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ...
read more
Thursday, February 16, 2012
Catalent Pharma Solutions, a leading global drug delivery technology company, and NewMarket Pharmaceuticals LLC have entered into an agreement to jointly formulate and develop a portfolio of products for treating production and companion animals ...
read more
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
read more
Tuesday, February 21, 2012
Service Eliminates Over-Packaging by Providing Deep Knowledge of a
Product’s Stability Barrier Needs Before It Is Packaged . . .
Leading to a “Just Right” Solution for Oral Dose Products in Six Weeks
read more
Wednesday, February 22, 2012
Global pharmaceutical manufacturer, Aesica, experienced significant growth in 2011, doubling both its turnover and its workforce and forming a number of long-term strategic partnerships with customers such as UCB and Noramco.
read more
Wednesday, February 22, 2012
NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc., announced that the Company has signed a manufacturing agreement with Florida Biologix for the production of the sterile liquid form of its Trappsol Cyclo product, an orphan ...
read more
Monday, February 27, 2012
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced it will be partnering with Charles River Laboratories International, Inc. of Wilmington, MA, to exclusively license EMD Millipore's TrueSpike™ technology. ...
read more
Tuesday, February 28, 2012
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, has addressed a surge in clinical outsourcing by acquiring two new pieces of encapsulation equipment at their North American headquarters in Souderton...
read more
Tuesday, February 28, 2012
Global pharmaceutical manufacturer and developer, Penn Pharma, has today [28 February 2012] announced a £14 million investment in its South Wales UK facility to strengthen its offering for international supply and further build on the company’s ...
read more
Wednesday, March 14, 2012
Recipharm and ViroPharma today signed a commercial contract to initiate supply of Plenadren® for named patient use. In addition, ViroPharma are investing in capital equipment at the Recipharm manufacturing site - enabling large scale manufacturing ...
read more
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ...
read more
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will feature Pierre Geoffroy, PhD, Vice President, Early Phase to discuss ethical principles related to ...
read more